Taiwanese (TAIEX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Jun 20, 2024

Discover Taiwanese Pharmaceuticals & Biotech Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

122 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4147

TaiMed Biologics
NT$88.90-2.2%-6.3%NT$24.3bNT$137.02PS40.5xE138.0%n/a

6535

Lumosa Therapeutics
NT$222.0017.2%303.6%NT$36.6bNT$244.00PS685.8xE111.0%n/a

6446

PharmaEssentia
NT$482.500.1%48.5%NT$160.2bNT$428.25PE362.3xE68.7%n/a

4743

Oneness Biotech
NT$151.501.7%-27.9%NT$68.8bNT$262.00PS761.4xE33.5%0%

6472

Bora Pharmaceuticals
NT$775.00-0.6%43.0%NT$78.0bNT$894.40PE28.8xE32.1%1.5%

1795

Lotus Pharmaceutical
NT$290.002.1%-5.8%NT$76.9bNT$393.20PE19.5xE24.6%1.6%

4162

PharmaEngine
NT$93.70-1.7%0.3%NT$13.5bNT$106.00PE49xE17.5%1.6%

8279

Syngen BiotechLtd
NT$162.504.8%-5.8%NT$4.4bNT$170.00PE16.8xE11.6%3.1%

6589

EirGenix
NT$86.603.1%-19.8%NT$26.5bNT$112.50PS25.8xE2.4%n/a

6562

UBI Pharma
NT$14.251.8%-62.3%NT$1.7bn/aPE2097.4xn/a0%

1752

Nang Kuang Pharmaceutical
NT$52.50-1.1%-14.5%NT$5.3bn/aPE33.3xn/a3.8%

6662

BioLASCO Taiwan
NT$37.001.2%19.4%NT$947.6mn/aPE20.4xn/a4.5%

4157

TaiGen Biopharmaceuticals Holdings
NT$15.150.7%-3.2%NT$10.9bn/aPE60.1xn/an/a

6564

Enimmune
NT$34.650.9%-30.4%NT$2.3bn/aPS52.4xn/an/a

4132

Golden Biotechnology
NT$22.050.7%-56.7%NT$3.1bn/aPS49.4xn/an/a

6620

Handa Pharmaceuticals
NT$108.00-1.4%-34.9%NT$15.2bNT$200.00PE25.5xn/a0.9%

4130

Genovate Biotechnology
NT$24.45-0.8%-17.5%NT$2.7bn/aPE81.2xn/a0.6%

7729

Steminent Biotherapeutics
NT$27.50-1.6%n/aNT$1.5bn/an/an/an/a

6827

MegaPro Biomedical
NT$21.60-6.1%-24.6%NT$1.4bn/an/an/an/a

3164

GenMont Biotech Incorporation
NT$23.90-2.4%-7.5%NT$2.1bn/aPE34.8xn/a2.9%

6733

BioGend Therapeutics
NT$38.807.0%-11.3%NT$4.8bNT$48.00PS35.8xn/an/a

6808

3D Global Biotech
NT$39.950.4%41.7%NT$2.7bn/aPS129.4xn/an/a

3176

Medigen Biotechnology
NT$43.30-2.5%31.8%NT$6.0bn/aPS4.8xn/an/a

6704

Gwo Xi Stem Cell Applied Technology
NT$35.25-5.0%-23.4%NT$3.4bn/aPS24xn/an/a
Page 1 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.